198 related articles for article (PubMed ID: 21449041)
1. Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding.
Yanni SB; Smith PB; Benjamin DK; Augustijns PF; Thakker DR; Annaert PP
Biopharm Drug Dispos; 2011 May; 32(4):222-32. PubMed ID: 21449041
[TBL] [Abstract][Full Text] [Related]
2. In vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats.
Yanni SB; Augustijns PF; Benjamin DK; Brouwer KL; Thakker DR; Annaert PP
Drug Metab Dispos; 2010 Oct; 38(10):1848-56. PubMed ID: 20606004
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of an elevated dosage of micafungin in premature neonates.
Smith PB; Walsh TJ; Hope W; Arrieta A; Takada A; Kovanda LL; Kearns GL; Kaufman D; Sawamoto T; Buell DN; Benjamin DK
Pediatr Infect Dis J; 2009 May; 28(5):412-5. PubMed ID: 19319022
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of micafungin in neonates and young infants.
Hope WW; Smith PB; Arrieta A; Buell DN; Roy M; Kaibara A; Walsh TJ; Cohen-Wolkowiez M; Benjamin DK
Antimicrob Agents Chemother; 2010 Jun; 54(6):2633-7. PubMed ID: 20308367
[TBL] [Abstract][Full Text] [Related]
5. Echinocandin use in the neonatal intensive care unit.
Caudle KE; Inger AG; Butler DR; Rogers PD
Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
[TBL] [Abstract][Full Text] [Related]
6. Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.
Mehta PA; Vinks AA; Filipovich A; Bleesing J; Jodele S; Jordan MB; Marsh R; Tarin R; Edwards S; Fearing D; Lawrence J; Davies SM
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1458-62. PubMed ID: 20546908
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Safety of Micafungin in Infants Supported With Extracorporeal Membrane Oxygenation.
Autmizguine J; Hornik CP; Benjamin DK; Brouwer KL; Hupp SR; Cohen-Wolkowiez M; Watt KM
Pediatr Infect Dis J; 2016 Nov; 35(11):1204-1210. PubMed ID: 27314826
[TBL] [Abstract][Full Text] [Related]
8. High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis.
Auriti C; Falcone M; Ronchetti MP; Goffredo BM; Cairoli S; Crisafulli R; Piersigilli F; Corsetti T; Dotta A; Pai MP
Antimicrob Agents Chemother; 2016 Dec; 60(12):7333-7339. PubMed ID: 27697761
[TBL] [Abstract][Full Text] [Related]
9. [Why might micafungin be the drug of choice in pediatric patients?].
Ramos Amador JT; Prieto Tato L; Guillén Martín S
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():23-8. PubMed ID: 21420573
[TBL] [Abstract][Full Text] [Related]
10. [Drug interactions in critically-ill patients. An important factor in the use of micafungin?].
Garnacho-Montero J; Jiménez Parrilla F
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():33-7. PubMed ID: 21420575
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin does not alter the pharmacokinetics of micafungin, but it impairs biliary excretion of micafungin via multidrug resistance-associated protein 2 (ABCC2/Mrp2) in rats.
Noda T; Abe F; Ueyama J; Kato M; Katoh M; Nadai M; Saito H; Hasegawa T
J Infect Chemother; 2011 Apr; 17(2):207-13. PubMed ID: 20835743
[TBL] [Abstract][Full Text] [Related]
12. Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients.
Walsh TJ; Goutelle S; Jelliffe RW; Golden JA; Little EA; DeVoe C; Mickiene D; Hayes M; Conte JE
Antimicrob Agents Chemother; 2010 Aug; 54(8):3451-9. PubMed ID: 20439610
[TBL] [Abstract][Full Text] [Related]
13. Reduced elimination clearance of micafungin in rats with cholestatic hyperbilirubinemia.
Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Takada K; Yamaji A
Fundam Clin Pharmacol; 2010 Aug; 24(4):457-62. PubMed ID: 19845766
[TBL] [Abstract][Full Text] [Related]
14. [Differential pharmacokinetic characteristics of micafungin. Experience in special populations].
Grau Cerrato S; Luque Pardos S; Ferrández Quirante O
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():10-4. PubMed ID: 21420571
[TBL] [Abstract][Full Text] [Related]
15. Micafungin concentrations in the plasma and burn eschar of severely burned patients.
Sasaki J; Yamanouchi S; Kudo D; Endo T; Nomura R; Takuma K; Kushimoto S; Shinozawa Y; Kishino S; Hori S; Aikawa N
Antimicrob Agents Chemother; 2012 Feb; 56(2):1113-5. PubMed ID: 22083486
[TBL] [Abstract][Full Text] [Related]
16. Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients.
Vossen MG; Knafl D; Haidinger M; Lemmerer R; Unger M; Pferschy S; Lamm W; Maier-Salamon A; Jäger W; Thalhammer F
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584142
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature.
Kofla G; Ruhnke M
Eur J Med Res; 2011 Apr; 16(4):159-66. PubMed ID: 21486730
[TBL] [Abstract][Full Text] [Related]
18. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
Cross SA; Scott LJ
Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009
[TBL] [Abstract][Full Text] [Related]
19. The management of Candida infections in preterm neonates and the role of micafungin.
Manzoni P; Benjamin DK; Hope W; Rizzollo S; Del Sordo P; Stronati M; Jacqz-Aigrain E; Castagnola E; Farina D
J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():24-7. PubMed ID: 21749182
[TBL] [Abstract][Full Text] [Related]
20. Bronchopulmonary disposition of micafungin in healthy adult volunteers.
Nicasio AM; Tessier PR; Nicolau DP; Knauft RF; Russomanno J; Shore E; Kuti JL
Antimicrob Agents Chemother; 2009 Mar; 53(3):1218-20. PubMed ID: 19114675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]